EUCREAS 50 mg/1000 mg, film-coated tablet 60 tablets, CIP 3400927349010
Active ingredients: Metformin, Metformin hydrochloride, Vildagliptin
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet60 tablets, CIP 3400927349010orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- EUCREAS 50 mg/1000 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) (ACLAR RX) polytrifluorochloroéthylène PVC-Aluminium de 60 comprimé(s)
- Marketing authorisation holder
- NOVARTIS EUROPHARM (IRLANDE)
- Reimbursement according to BDPM
- 15 %
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 8 Nov 2021
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60892792CIP72734901CIP133400927349010Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| METFORMINEcomprimé | 780 mg · un comprimé | FT |
| METFORMINE (CHLORHYDRATE DE)comprimé | 1000,0 mg · un comprimé | SA |
| VILDAGLIPTINEcomprimé | 50,0 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.